Regeneron Pharmaceuticals
REGN
#328
Rank
$74.72 B
Marketcap
$712.77
Share price
-0.30%
Change (1 day)
24.20%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): $5.15 Billion USD

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are $14.91 Billion USD. In 2025 the company made an earning of $5.23 Billion USD, an increase over its 2024 earnings that were of $4.77 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $5.15 B-1.41%
2025 $5.23 B9.43%
2024 $4.77 B13.83%
2023 $4.19 B-13.57%
2022 $4.85 B-47.9%
2021 $9.32 B144.75%
2020 $3.81 B56.86%
2019 $2.42 B-4.87%
2018 $2.55 B22.86%
2017 $2.07 B56.3%
2016 $1.32 B8.55%
2015 $1.22 B54.53%
2014 $0.79 B11.14%
2013 $0.71 B72.13%
2012 $0.41 B-285.93%
2011 -$0.23 Billion121.73%
2010 -$0.11 Billion37.18%
2009 -$73.28 Million-14.6%
2008 -$85.82 Million-25.02%
2007 -$0.12 Billion6.32%
2006 -$0.11 Billion-186.52%
2005 $0.12 B2103.7%
2004 $5.64 M-105.66%
2003 -$99.78 Million-18.18%
2002 -$0.13 Billion42.33%
2001 -$85.69 Million129.35%
2000 -$37.36 Million51.87%
1999 -$24.6 Million92.19%
1998 -$12.8 Million66.23%
1997 -$7.7 Million-55.49%
1996 -$17.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.78 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
$9.08 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.65 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$1.62 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.86 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA